These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 31048658)

  • 1. Adiponectin for the treatment of diabetic nephropathy.
    Lee JY; Yang JW; Han BG; Choi SO; Kim JS
    Korean J Intern Med; 2019 May; 34(3):480-491. PubMed ID: 31048658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
    Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
    J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of Glomerular Hyperfiltration: The Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity.
    Chagnac A; Zingerman B; Rozen-Zvi B; Herman-Edelstein M
    Nephron; 2019; 143(1):38-42. PubMed ID: 30947190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
    Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
    Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte hypertrophy in diabetic nephropathy.
    Kim NH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy.
    Kumar Pasupulati A; Chitra PS; Reddy GB
    Biomol Concepts; 2016 Dec; 7(5-6):293-309. PubMed ID: 27816946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway.
    Yang S; Ma C; Wu H; Zhang H; Yuan F; Yang G; Yang Q; Jia L; Liang Z; Kang L
    Pharmacol Res; 2020 Mar; 153():104678. PubMed ID: 32014572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q/Tumor Necrosis Factor-Related Protein-9 Attenuates Diabetic Nephropathy and Kidney Fibrosis in db/db Mice.
    Hu H; Li W; Liu M; Xiong J; Li Y; Wei Y; Huang C; Tang Y
    DNA Cell Biol; 2020 Jun; 39(6):938-948. PubMed ID: 32283037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A translational model of chronic diabetic nephropathy in the Nile grass rat.
    Naseri M; Ranaei Pirmardan E; Melhorn MI; Zhang Y; Barakat A; Hafezi-Moghadam A
    FASEB J; 2024 Jul; 38(14):e23789. PubMed ID: 39018098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
    Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
    Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.
    Subathra M; Korrapati M; Howell LA; Arthur JM; Shayman JA; Schnellmann RG; Siskind LJ
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F204-15. PubMed ID: 26041445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy.
    Sun YM; Su Y; Li J; Wang LF
    Biochem Biophys Res Commun; 2013 Apr; 433(4):359-61. PubMed ID: 23541575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent Insulin Resistance in Podocytes Caused by Epigenetic Changes of SHP-1 in Diabetes.
    Lizotte F; Denhez B; Guay A; Gévry N; Côté AM; Geraldes P
    Diabetes; 2016 Dec; 65(12):3705-3717. PubMed ID: 27585521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy.
    Kumar PA; Brosius FC; Menon RK
    Curr Diabetes Rev; 2011 Jan; 7(1):50-5. PubMed ID: 21067510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dipeptidyl peptidase 4 inhibitor sitagliptin improves oxidative stress and ameliorates glomerular lesions in a rat model of type 1 diabetes.
    Marques C; Gonçalves A; Pereira PMR; Almeida D; Martins B; Fontes-Ribeiro C; Reis F; Fernandes R
    Life Sci; 2019 Oct; 234():116738. PubMed ID: 31398418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klotho plays a protective role against glomerular hypertrophy in a cell cycle-dependent manner in diabetic nephropathy.
    Oh HJ; Nam BY; Wu M; Kim S; Park J; Kang S; Park JT; Yoo TH; Kang SW; Han SH
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F791-F805. PubMed ID: 29638159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte biology in diabetic nephropathy.
    Li JJ; Kwak SJ; Jung DS; Kim JJ; Yoo TH; Ryu DR; Han SH; Choi HY; Lee JE; Moon SJ; Kim DK; Han DS; Kang SW
    Kidney Int Suppl; 2007 Aug; (106):S36-42. PubMed ID: 17653209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.